Effects and Efficacy of Anisodamine (654-2)

Anisodamine (brand name: 654-2) is an antimuscarinic (anticholinergic) agent, also known as anisodamine hydrobromide. It is primarily used to relieve smooth muscle spasm, gastrointestinal colic, biliary colic, microcirculatory disorders, and organophosphate poisoning. Common adverse effects include dry mouth, facial flushing, blurred vision, and occasionally tachycardia.

Pharmacological Effects and Clinical Uses of 654-2

1. Relief of Severe Biliary and Gastrointestinal Pain

This drug may be used to alleviate severe gastrointestinal pain. However, its use prior to establishing a definitive diagnosis may mask or obscure abdominal symptoms, thereby interfering with accurate clinical assessment. Therefore, it should only be administered after confirming that abdominal pain is attributable to conditions such as cholecystitis, cholelithiasis, or renal calculi.

2. Treatment of Organophosphate Poisoning

Its mechanism of action is similar to that of atropine, effectively counteracting organophosphate-induced cholinergic toxicity.

3. Management of Vertigo

This drug—either orally or via injection—can effectively alleviate vertigo (a sensation of spinning or dizziness), but not general lightheadedness or presyncope. Note: “Vertigo” specifically refers to the illusion of motion or spinning, distinct from non-rotational dizziness.

4. Improvement of Microcirculation

It can enhance peripheral microcirculation and is sometimes employed in the supportive management of shock.

Drug Interactions of 654-2

1. Concurrent use with amantadine, phenothiazines, tricyclic antidepressants, primidone, procainamide, or other anticholinergic agents may potentiate adverse effects.

2. Concomitant administration with monoamine oxidase inhibitors (MAOIs)—including furazolidone and methylbenzhydrazine—may intensify antimuscarinic side effects.

3. As an inhibitor of gastrointestinal motility, 654-2 delays gastric emptying, thereby influencing the absorption kinetics of certain drugs: for example, prolonged gastric residence of erythromycin may reduce its efficacy; absorption of acetaminophen (paracetamol) may be delayed; while absorption of digoxin and nitrofurantoin may be increased.

The above outlines the pharmacological actions and clinical applications of 654-2. We hope this information proves helpful.